FindTrial
Sign In

Research on surfactant for the treatment of neonatal respiratory distress syndrome

Research on different dose of surfactant regimens for the treatment of neonatal respiratory distress syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OON-15006258
Enrollment
Unknown
Registered
2015-04-08
Start date
2015-04-08
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal respiratory distress syndrome

Interventions

Two groups:Calsurf application

Sponsors

First affiliated hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: Premature infants, birth weight <2500 g, with RDS of neonatal intensive care units

Exclusion criteria

Exclusion criteria: Respiratory failure not due to RDS, major congenital abnormalities considered to be life threatening or anomalies interfering with lung development or function (such as cyanotic congenital heart disease, pulmonary hypoplasia, hydrops fetalis and diaphragmatic hernias), sepsis, severe birth asphyxia (Apgar score of <=3 at 10 minutes) and intracranial haemorrhage (grades III or IV), informed written parental consent was not required.

Design outcomes

Primary

MeasureTime frame
mortality;PaO2;PaCO2;FiO2;OI;—

Secondary

MeasureTime frame
a/APO2;duration of ventilatory requirements;duration of oxygen inhalation;—

Countries

China

Contacts

Public ContactChen Xiaoqing
chenxq2002@foxmail.com+86 13951676702

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026